For patients with stage T1a renal cell carcinoma (RCC), the use of thermal ablation has been increasing, while the use of radical nephrectomy has been declining.
Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...
Stage 4 RCC is metastatic, with common spread to lungs, bones, liver, brain, and adrenal glands. Understanding IMDC risk is ...
Ferroptosis, a regulated cell death mechanism, is emerging as a promising target for cancer therapy. The process is mediated by the activity of acyl-CoA synthetase family member 4 (ACSL4) protein.
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
There is currently no effective therapy for patients with advanced HLRCC-associated papillary renal cell carcinoma. Treatment with bevacizumab and erlotinib resulted in a confirmed response of 72% in ...
Ferroptosis, a newly discovered regulated cell death mechanism is recognized for its role in cancer therapies. However, ferroptosis regulation in renal cancer cells is not yet established. In this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback